Info

Researchers are conducting a study to evaluate a colon cancer screening test designed to help identify individuals who may be at risk for colorectal cancer. The goal of this research is to improve early detection and support better health outcomes through effective screening methods.

Participation in this study may help researchers develop and validate screening tools that could benefit future patients.

Fatty Liver/NASH/MASH (Please keep image and delete information and study info for EBGCR) 

Non Alcoholic Steatohepatitis (NASH) is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver.

NASH is closely related to the triple epidemic of obesity, pre-diabetes, and diabetes.  If you are living with NASH you may qualify for a clinical research study.

MASH is the advanced stage of MASLD. MAFLD is a type of metabolic syndrome characterized by being overweight or obese, elevated blood pressure, blood lipids, and either diabetes or pre-diabetes. Researchers believe that oxidative stress, inflammatory proteins, liver cell damage, adipose tissue inflammation, and the gut microbiota may contribute to its development.

Join Encore Borland Groover Clinical Research (EBGCR) for a complimentary Fibroscan test for fatty liver. 

ClinicalTrials.gov- Study Details

Contact Research: 

Ana Corregidor, MD

Gastroenterologist

Borland Groover

4800 Belfort Road

Jacksonville FL 32256

Contact Research: (904) 680-0871

Research Email: ACorregidor@EncoreDocs.com

Michael Herman, MD

Gastroenterologist

Borland Groover

1679 Eagle Harbor Parkway

Suite D

Fleming Island FL 32003

Contact Research: (904) 621-0390

Research Email: MHerman@EncoreDocs.com

Linda Di Teodoro, MD

Gastroenterologist

Borland Groover

4800 Belfort Road

Jacksonville FL 32003

Contact Research: 904-680-0871

NIKHIL KAPILA, MD

Gastroenterologist

Borland Groover

Work Phone: 904-680-0871

Read the latest posts by our expert clinical staff!